59 related articles for article (PubMed ID: 7574776)
1. [T cell receptor V beta repertoire of locoregional lymphocytes in malignant effusions].
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Funakoshi M; Takashima I; Sawamura A; Toge T
Gan To Kagaku Ryoho; 1995 Sep; 22(11):1622-5. PubMed ID: 7574776
[TBL] [Abstract][Full Text] [Related]
2. Profile of T-cell receptor V beta gene usage of cytotoxic T cells induced by intrapleural administration of a streptococcal preparation, OK432, in malignant effusions.
Miyahara E; Yamaguchi Y; Hihara J; Noma K; Toge T
J Exp Ther Oncol; 1996 Jul; 1(4):242-50. PubMed ID: 9414411
[TBL] [Abstract][Full Text] [Related]
3. Flow cytometric quantitation of natural killer cells and T lymphocytes expressing T-cell receptors alpha/beta and gamma/delta is not helpful in distinguishing benign from malignant body cavity effusions.
Cornfield DB; Gheith SM
Cytometry B Clin Cytom; 2009 May; 76(3):213-7. PubMed ID: 18803280
[TBL] [Abstract][Full Text] [Related]
4. Analysis of T-cell receptor V region gene usage of cytotoxic T-lymphocytes and tumor-infiltrating lymphocytes derived from human autologous gastric signet ring cell carcinomas.
Ikeda H; Sato N; Matsuura A; Kikuchi K
Cancer Res; 1993 Jul; 53(13):3078-84. PubMed ID: 8391386
[TBL] [Abstract][Full Text] [Related]
5. Evidence for T-cell clonal expansion in a patient with squamous cell carcinoma of the head and neck.
Caignard A; Dietrich PY; Morand V; Lim A; Pannetier C; Leridant AM; Hercend T; Even J; Kourilsky P; Triebel F
Cancer Res; 1994 Mar; 54(5):1292-7. PubMed ID: 8118818
[TBL] [Abstract][Full Text] [Related]
6. Changes in the T-cell receptor V beta gene repertoire after allogeneic hematopoietic stem cell transplantation.
Liu QF; Li YQ; Yang D; Zhang Y; Yang LJ; Chen SH; Sun J; Liu XL; Zhou SY
Chin Med J (Engl); 2004 Mar; 117(3):413-8. PubMed ID: 15043783
[TBL] [Abstract][Full Text] [Related]
7. Combined immunotherapy with intracavital injection of activated lymphocytes, monocyte-derived dendritic cells and low-dose OK-432 in patients with malignant effusion.
Morisaki T; Matsumoto K; Kuroki H; Kubo M; Baba E; Onishi H; Tasaki A; Nakamura M; Inaba S; Katano M
Anticancer Res; 2003; 23(6a):4459-65. PubMed ID: 14666734
[TBL] [Abstract][Full Text] [Related]
8. In vivo local expansion of clonal T cell subpopulations in renal cell carcinoma.
Gaudin C; Dietrich PY; Robache S; Guillard M; Escudier B; Lacombe MJ; Kumar A; Triebel F; Caignard A
Cancer Res; 1995 Feb; 55(3):685-90. PubMed ID: 7834641
[TBL] [Abstract][Full Text] [Related]
9. The alpha beta T-cell receptor repertoire in inclusion body myositis: diverse patterns of gene expression by muscle-infiltrating lymphocytes.
O'Hanlon TP; Dalakas MC; Plotz PH; Miller FW
J Autoimmun; 1994 Jun; 7(3):321-33. PubMed ID: 7916906
[TBL] [Abstract][Full Text] [Related]
10. T cell receptor V beta 2 and V beta 6 mediate tumor-specific cytotoxicity by tumor-infiltrating lymphocytes in ovarian cancer.
Peoples GE; Davey MP; Goedegebuure PS; Schoof DD; Eberlein TJ
J Immunol; 1993 Nov; 151(10):5472-80. PubMed ID: 8228239
[TBL] [Abstract][Full Text] [Related]
11. Locoregional immunotherapy of malignant ascites from gastric cancer using DTH-oriented doses of the streptococcal preparation OK-432: Treatment of Th1 dysfunction in the ascites microenvironment.
Yamaguchi Y; Ohshita A; Kawabuchi Y; Hihara J; Miyahara E; Noma K; Toge T
Int J Oncol; 2004 Apr; 24(4):959-66. PubMed ID: 15010836
[TBL] [Abstract][Full Text] [Related]
12. Evidence for oligoclonal T-cell response in a metastasis of renal cell carcinoma responding to vaccination with autologous tumor cells and transfer of in vitro-sensitized vaccine-draining lymph node lymphocytes.
Weidmann E; Logan TF; Yasumura S; Kirkwood JM; Trucco M; Whiteside TL
Cancer Res; 1993 Oct; 53(20):4745-9. PubMed ID: 8402652
[TBL] [Abstract][Full Text] [Related]
13. Down-regulation of IL-10 enhances the efficacy of locoregional immunotherapy using OK-432 against malignant effusion.
Hihara J; Yamaguchi Y; Minami K; Noma K; Toge T
Anticancer Res; 1999; 19(2A):1077-84. PubMed ID: 10368657
[TBL] [Abstract][Full Text] [Related]
14. T-cell receptor beta chain variability in bone marrow and peripheral blood in severe acquired aplastic anemia.
Manz CY; Dietrich PY; Schnuriger V; Nissen C; Wodnar-Filipowicz A
Blood Cells Mol Dis; 1997; 23(1):110-22. PubMed ID: 9215756
[TBL] [Abstract][Full Text] [Related]
15. Lymphocytes infiltrating rat cardiac allografts express a limited repertoire of T cell receptor V beta genes.
Shirwan H; Chi D; Makowka L; Cramer DV
J Immunol; 1993 Nov; 151(10):5228-38. PubMed ID: 8228221
[TBL] [Abstract][Full Text] [Related]
16. T cell repertoire in patients with B chronic lymphocytic leukemia. Evidence for multiple in vivo T cell clonal expansions.
Farace F; Orlanducci F; Dietrich PY; Gaudin C; Angevin E; Courtier MH; Bayle C; Hercend T; Triebel F
J Immunol; 1994 Nov; 153(9):4281-90. PubMed ID: 7930628
[TBL] [Abstract][Full Text] [Related]
17. Differential usage of T cell receptor V gene segments in CD4+ and CD8+ subsets of T lymphocytes in monozygotic twins.
Hawes GE; Struyk L; van den Elsen PJ
J Immunol; 1993 Mar; 150(5):2033-45. PubMed ID: 8436833
[TBL] [Abstract][Full Text] [Related]
18. [T cell repertoires correlate with pathogenesis of chronic idiopathic thrombocytopenic purpura].
Zhu X; Zhu P; Guo XL
Zhonghua Yi Xue Za Zhi; 2005 Dec; 85(47):3316-22. PubMed ID: 16409835
[TBL] [Abstract][Full Text] [Related]
19. [Analysis of 5-year survival among breast cancer patients with malignant pleural effusion receiving intrapleural OK-432 followed by adoptive transfer with cultured effusion lymphocytes].
Kan N
Gan To Kagaku Ryoho; 2003 Oct; 30(11):1559-61. PubMed ID: 14619463
[TBL] [Abstract][Full Text] [Related]
20. [Restricted usage of repertoire of T-cell receptor V beta in Chinese asthmatics].
Guo X; Li W; Deng W; Ni P; Yu S; Li Y; Zhang H
Zhonghua Jie He He Hu Xi Za Zhi; 2002 Feb; 25(2):78-80. PubMed ID: 11953102
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
